5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores

PHASE2CompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

February 23, 2021

Study Completion Date

March 3, 2021

Conditions

Crohn DiseaseUlcerative ColitisFatigueRemission

Interventions

DRUG

5-HTP

8 weeks active substance 5-HTP (2 x 100mg per day)

DRUG

Placebo oral capsule

8 weeks placebo (2 x 1 caps per day)

Trial Locations (13)

Ghent University Hospital, Ghent

AZ Imelda, Bonheiden

CHU Saint-Pièrre, Brussels

UCL Saint-Luc, Brussels

ULB Erasme, Brussels

UZ Brussel, Brussels

AZ Maria Middelares, Ghent

AZ Sint-Lucas, Ghent

UZ Leuven, Leuven

CHU Liège, Liège

CHU Namur, Namur

AZ Damiaan, Ostend

AZ Nikolaas, Sint-Niklaas

All Listed Sponsors

lead

University Hospital, Ghent

OTHER

NCT03574948 - 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores | Biotech Hunter | Biotech Hunter